It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

The controversial biohacker has detailed his latest experiment in age reversal using full plasma replacement therapy.

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

HealthSpotlight offers in-depth insights and expert analysis on the latest research, trends, and resources related to Myasthenia Gravis. Our weekly newsletter covers essential topics, including ...

Background: Sepsis is a life-threatening condition caused by severe infection. The efficacy of intravenous immunoglobulin (IVIG) as adjunctive therapy on mortality remains controversial. Moreover, ...

Background We report our experience of patients with generalised myasthenia gravis (gMG ... 54.2% of patients required regular intravenous immunoglobulin/plasma exchange. 75% of patients had a mean ...

An example is generalized Myasthenia Gravis (gMG) where IgG targets neuromuscular receptor proteins leading to degenerative neurological disease. In Immune Thrombocytopenia (ITP), IgG targets ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Myasthenia gravis (MG) is an autoimmune disorder involving complex interactions between genetic and environmental factors. Genome-wide association studies (GWAS), transcriptome-wide association ...